| Product NDC: | 0065-1795 |
| Proprietary Name: | BSS |
| Non Proprietary Name: | balanced salt solution |
| Active Ingredient(s): | .48; .3; .75; 3.9; 6.4; 1.7 mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL & nbsp; balanced salt solution |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0065-1795 |
| Labeler Name: | Alcon Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020742 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19690328 |
| Package NDC: | 0065-1795-04 |
| Package Description: | 500 mL in 1 BAG (0065-1795-04) |
| NDC Code | 0065-1795-04 |
| Proprietary Name | BSS |
| Package Description | 500 mL in 1 BAG (0065-1795-04) |
| Product NDC | 0065-1795 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | balanced salt solution |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19690328 |
| Marketing Category Name | NDA |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE |
| Strength Number | .48; .3; .75; 3.9; 6.4; 1.7 |
| Strength Unit | mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL |
| Pharmaceutical Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |